UNICAB: Cabozantinib in Locally Advanced or Metastatic Non‐clear Cell Renal Cell Carcinoma Post Immunotherapy or in Those Unsuitable for Immunotherapy (ANZUP 1802).
JOURNAL OF CLINICAL ONCOLOGY（2024）
Key words
261-566-9718-9794,261-374,261-492-199,298-145-222-184-1023-8966,171,14,171
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined